AnserBio

AnserBio is at the forefront of biotechnology research, pioneering innovative solutions in cancer treatment. With a focus on developing a novel approach through healthy p53 protein delivery into tumor cells, AnserBio is dedicated to advancing medical science and improving patient outcomes. Their unique method holds the potential to benefit the treatment of a significant portion of human cancers, either as a standalone therapy or in combination with other agents.

Located at 47 HaTaasiya, Nesher, Haifa District 3688847, IL, AnserBio operates with a commitment to excellence and a vision for a future where cancer is more effectively managed. The company is driven by a passion for innovation and a dedication to making a meaningful impact on global healthcare.

AnserBio continues to expand its research and development efforts, striving to bring cutting-edge therapies to market. We invite the management team at AnserBio to create a customized and exclusive company showcase and product listing on our platform, highlighting their contributions to the biotechnology field.